(Q44846900)

English

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

oligodendroglioma

1 reference

based on heuristic

inferred from title

0 references

author name string

Netta Levin

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Iris Lavon

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Bracha Zelikovitsh

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Dana Fuchs

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Felix Bokstein

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Yakov Fellig

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Tali Siegal

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

106

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

1759-1765

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

21 January 2018

Low grade glial neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of temozolomide in patients with progressive low-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21809

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21809

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

http://europepmc.org/abstract/MED/16541434

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44846900&oldid=2053246377"